Report

VIJAYA DIAGNOSTIC CENTRE, Dilsukhnagar
Age / Gender: 35/Female Date and Time: 23rd Mar 24 10:33 AM

Patient ID: 240120040196
Patient Name: Mrs. K KARUNA SHREE
240120040196-Mrs. K KARUNA SHREE-35 Years-Female
AR: 85bpm VR: 81bpm QRSD: 93ms QT: 372ms QTcB: 432.23ms PRI: 149ms P-R-T: NA
REPORTED BY
ECG Within Normal Limits: Normal sinus rhythm. Please correlate clinically.
DR. G. D. PRASAD
MD. DM
Disclaimer: Analysis in this report is based on ECG alone and should only be used as an adjunct to clinical history, symptoms and results of other invasive and non-invasive tests and must be interpreted by a qualified physician.
109026
Opp.Metro Pillar No. A1516, Indira Nagar, Dilsukhnagar, Hyderabad - 500089
TEST REPORT
Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

Age/Gender : 35 Years / Female Collected on : 23-Mar-2024 09:39
Registration ID : 240120040196 Released on : 23-Mar-2024 12:38
Ref. By : STATE BANK OF INDIA Printed on : 25-Mar-2024 09:01
Sample Type : Serum Regn Centre : Dilsukhnagar - 12
CREATININE
TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Creatinine : 0.8 mg/dL 0.5 - 1.0
Method: Jaffe Kinetic IDMS traceable
Interpretation / Comments :
-------------------------------
• Useful in the diagnosis of renal insufficiency and is more specific and sensitive indicator of renal disease than BUN.
• Use of simultaneous BUN and creatinine levels provide more information in the diagnosis of renal insufficiency.
DR. SUJANA REDDY

MD BIOCHEMISTRY
Registration No: 61171
Page 2 of 21
TEST REPORT

URIC ACID

Uric Acid : 6.4 mg/dL 2.6 - 6.0
Method: Uricase-Peroxidase
----------------------------------
• Useful for monitoring therapeutic management of gout and chemotherapeutic treatment of neoplasms.
DR. SUJANA REDDY

MD BIOCHEMISTRY
Page 3 of 21
TEST REPORT

Sample Type : Whole Blood - EDTA Regn Centre : Dilsukhnagar - 12
COMPLETE BLOOD PICTURE (CBP)

Haemoglobin : 12.3 gm/dL 12.0 - 15.0
Method: Photometric Measurement
Total RBC Count : 4.7 millions/cumm 3.8 - 4.8
Method: Coulter Principle
Packed Cell Volume / Hematocrit : 36.8 % 36.0 - 46.0
Method: Calculated
MCV : 78.8 fL 83.0 - 101.0
Method: Derived From RBC Histogram
MCH : 26.4 pg 27.0 - 32.0

Method: Calculated
MCHC : 33.5 gm/dL 31.5 - 34.5
Method: Calculated
RDW : 13.3 % 11.6 - 14.0
Method: Derived From RBC Histogram
Total Leucocytes (WBC) Count : 6700 Cells/cumm 4000 - 10000
Method: Coulter Principle
Differential count
Neutrophils : 55 % 40 - 80
Method: VCSn Technology and Microscopy
Lymphocytes : 31 % 20 - 40
Eosinophils :4 % 1-6
Monocytes : 10 % 2 - 10
Basophils :0 % 0-2
Absolute Leucocyte Count
Absolute Neutrophil Count : 3685 Cells/cumm 2000 - 7000
Method: Calculated
Absolute Lymphocyte Count : 2077 Cells/cumm 1000 - 3000
Method: Calculated
Absolute Eosinophil Count : 268 Cells/cumm 20 - 500
Method: Calculated
Absolute Monocyte Count : 670 Cells/cumm 200 - 1000
Method: Calculated
Page 4 of 21
TEST REPORT

COMPLETE BLOOD PICTURE (CBP)

Platelet Count : 260000 Cells/cumm 150000 - 410000
Method: Coulter Principle and Microscopy
Peripheral Smear
RBC : Normocytic Normochromic
Method: Microscopy of Leishman stained smear
WBC : Normal in morphology, maturity and distribution
Platelets : Adequate
DR. NADIA JABEEN

MD PATHOLOGY
Registration No: APMC/FMR/94054
Page 5 of 21
TEST REPORT

Sample Type : Urine Regn Centre : Dilsukhnagar - 12
CUE (COMPLETE URINE EXAMINATION)

Physical Examination
Colour : Yellow Pale Yellow
Method: Physical Examination
Appearance : Clear Clear
Method: Physical Examination
Specific Gravity : 1.030 1.003 - 1.030
Method: Ion Exchange
Chemical Examination
Reaction/pH : Acidic (5.5) 4.6 - 8
Method: Reagent Strip Method / Double Indicator

Protein : Nil Nil-Trace
Method : Reagent Strip/Protein error of Indicator
Glucose : Nil Nil
Method: GOD-POD
Urobilinogen : Normal NA
Method : Reagent Strip/Modified Ehrlich reaction
Bilirubin : Negative Negative
Method: Diazonium
Ketones : Negative Negative
Method: Nitrite reaction/Reagent strip
Nitrites : Negative Negative
Method: Diazonium
Microscopic Examination
Pus Cells : 1-2 cells / HPF 0-5
RBC : 0-1 cells / HPF 0-2
Epithelial Cells : 2-4 cells / HPF 0-5
Casts : Nil Nil
Crystals : Nil Nil
Method : Reagent Strip Method, Microscopy
DR. NADIA JABEEN

MD PATHOLOGY
Registration No: APMC/FMR/94054
Page 6 of 21
TEST REPORT

TSH-ULTRASENSITIVE

TSH - Ultrasensitive : 2.432 µIU/mL Non pregnant : 0.55 - 4.78
Method: Chemiluminiscence Immunoassay Pregnant
1st Trimester : 0.3 - 4.5
2nd Trimester : 0.5 - 4.6
3rd Trimester : 0.8 - 5.2
Interpretation:-
• This test is especially useful in the differential diagnosis of primary (thyroid) from secondary (pituitary) and tertiary
(hypothalamus) Hypothyroidism.
• TSH assays with increased sensitivity and specificity provide a primary diagnostic tool to differentiate hyperthyroid
from euthyroid patients.
• Helpful in monitoring T4 replacement or T4 supressive therapy.
• Helpful to Quantify TSH levels in the subnormal range.
• TSH levels are subjected to circadian variation, hence the time of the day has influence on the measure serum TSH
concentrations.
• TSH levels are increased in Primary hypothyroidism, subclinical hypothyroidism.
• TSH levels are decreased in Graves disease, Primary hyperthyroidism, TSH deficiency.
DR. SUJANA REDDY

MD BIOCHEMISTRY
Page 7 of 21
TEST REPORT

BILIRUBIN

Total Bilirubin : 0.4 mg/dL 0.3 - 1.2
Method: Dichlorophenyl Diazonium Tetrafluoroborate
Direct Bilirubin : 0.1 mg/dL < 0.2
Method: Dichlorophenyl Diazonium Tetrafluoroborate
Indirect Bilirubin : 0.3 mg/dL <1.0
Method: Calculation
-------------------------------
• Useful in assessing liver function and evaluating a wide range of diseases affecting
the production, uptake, storage metabolism or excretion of bilirubins.
• Useful in monitoring the efficacy of neonatal phototherapy.
• Helps in differentiating between prehepatic, hepatic & post hepatic hyperbilirubinemia.
DR. SUJANA REDDY

MD BIOCHEMISTRY
Page 8 of 21
TEST REPORT

LIPID PROFILE

Serum Status : Clear
Triglycerides : 62 mg/dL Desirable level : < 150
Method: Glycerol Phosphate Oxidase (GPO), Borderline : 150 - 199
Peroxidase (POD) High : 200 - 499
Very High : > / = 500
Total Cholesterol : 133 mg/dL Desirable : < 200
Method: Cholesterol Oxidase Peroxidase (CHOD- Borderline high : 200 - 239
POD) High : > / = 240
LDL Cholesterol : 75 mg/dL Optimal : < 100
Method: Calculated Near optimal : 100 - 129

Borderline high : 130 - 159
High : 160 - 189
Very high : > 190
HDL Cholesterol : 46 mg/dL Desirable level : > 60
Method: Enzymatic Immunoinhibition Optimal : 40 - 59
Undesriable : < 40
VLDL Cholesterol : 12 mg/dL < 30
Method: Calculation
Total Cholesterol / HDL Cholesterol : 2.9 Low risk : 3.3 - 4.4
Ratio Average risk : 4.5 - 7.1
Method: Calculation Moderate risk : 7.2 - 11.0
LDL Cholesterol / HDL Cholesterol : 1.6 Desirable level : 0.5 - 3.0
Ratio Borderline risk : 3.0 - 6.0
Method: Calculation High risk : > 6.0
------------------------------------
• Lipid profile is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities
in lipids, the results of this tests can identify certain genetic diseases and can determine approximate
risks for cardiovascular disease, certain forms of pancreatitis and other diseases.
DR. SUJANA REDDY

MD BIOCHEMISTRY
Page 9 of 21
TEST REPORT

ERYTHROCYTE SEDIMENTATION RATE (ESR)

ESR : 17 mm/hour 1 - 20
Method: Automated - Modified Westergren
----------------------------------
• ESR is a nonspecific parameter, clinically useful in disorders associated with an increased production of acute phase
proteins.
• Elevated in acute and chronic infections and malignancies.
• Extremely high ESR values are seen in Multiple myeloma, Leukemias, Lymphomas, breast and lung carcinomas,
Rheumatoid arthritis, Systemic Lupus Erythematosus and Pulmonary infarction.

• ESR is elevated in normal pregnancy
DR. RUDRA PRADEEP

MD PATHOLOGY
Registration No: TSMC/FMR/01226
Page 10 of 21

Age/Gender : 35 Years/Female Released on : 23-Mar-2024 12:52
Registration ID : 240120040196 Printed on : 25-Mar-2024 09:01
Ref. By : STATE BANK OF INDIA Regn Centre : Dilsukhnagar - 12
DEPARTMENT OF RADIOLOGY AND IMAGING SCIENCES

ULTRASOUND OF ABDOMEN & PELVIS
History : Abdominal distension.
Liver : Normal in size (132 mm) and shows increased echotexture. There is no
evidence of obvious intra or extrahepatic biliary dilatation. CBD and
portal vein appear normal.
Gall Bladder : Physiologically distended and shows no wall thickening. No obvious

intraluminal lesion seen.
Pancreas : Normal in size, shape and echopattern. No calcifications, duct dilatation

seen.
Spleen : Normal in size (89 mm), shape and echopattern.
Kidneys : Right kidney : 102 x 39 mm; Left kidney : 100 x 49 mm

Both kidneys are normal in size, shape and echo pattern.
Corticomedullary differentiation can be appreciated.
Collecting system appears normal.
Urinary Bladder : Well distended. No wall thickening seen. No obvious intraluminal lesion
seen.
Uterus : Size : 71 x 52 x 38 mm.

Anteverted. Normal in size, shape and echotexture.
Endometrial thickness measures 6.4 mm.
Cervix appears normal.
Ovaries : Right ovary : 48 x 43 x 20 mm, Volume - 23 cc.

Left ovary : 34 x 28 x 21 mm, Volume - 10 cc.
Both ovaries are bulky in size and show multiple (10 - 15) small (< 5 mm)
follicles arranged peripherally with central echogenic stroma. No
follicular differentiation noted - PCOD.
Page 11 of 21

Age/Gender : 35 Years/Female Released on : 23-Mar-2024 12:52
Registration ID : 240120040196 Printed on : 25-Mar-2024 09:01
Ref. By : STATE BANK OF INDIA Regn Centre : Dilsukhnagar - 12
DEPARTMENT OF RADIOLOGY AND IMAGING SCIENCES

ULTRASOUND OF ABDOMEN & PELVIS
Other Findings : No free fluid in Pouch of Douglas.
No ascites.
Small umbilical hernia (defect size ~ 11.8 mm) seen with omentum and
small bowel as contents.
Impression : * GRADE - I FATTY LIVER.
* BILATERAL POLYCYSTIC OVARIES.
* UMBILICAL HERNIA.
FOR CLINICAL CORRELATION / FURTHER EVALUATION.
MIS-2023-0192 DR. SIREESHA P

Consultant Radiologist
Reg No: 54002
Page 12 of 21
TEST REPORT

T3 TOTAL

T3 Total : 1.12 ng/mL Non pregnant : 0.60 - 1.81
Method: Chemiluminiscence Immunoassay Pregnant
1st Trimester : 0.81 - 1.90
2nd & 3rd Trimester : 1.0 - 2.60
---------------------------------
• Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many
factor such as stress, position, fasting state, time of the day, preceding diet and drug therapy.
• T3 is one of the thyroid hormones derived due to peripheral conversion of T4.

• The levels of T3 helps in the diagnosis of T3 thyrotoxicosis and monitoring the course of hyperthyroidism.
• T3 is not recommended for diagnosis of hypothyroidism as decreased values have minimal clinical significance.
• Values below the lower limits can be caused by a number of conditions including non-thyroidal illness,
acute and chronic stress and hypothyroidism.
DR. SUJANA REDDY

MD BIOCHEMISTRY
Page 13 of 21
TEST REPORT

SGPT / ALT (ALANINE TRANSAMINASE)

SGPT/ALT : 17 U/L 0 - 35
Method: IFCC without P-5-P
------------------------------------
• Most sensitive test for acute hepatocellular injury (eg. viral, drug). It precedes the increase in serum bilirubin by
approximately one week.
DR. SUJANA REDDY

MD BIOCHEMISTRY
Page 14 of 21
TEST REPORT

ALKALINE PHOSPHATASE

Alkaline Phosphatase : 93 U/L 33 - 98
Method: Kinetic PNPP-AMP
----------------------------
• The most common cause of elevated ALP is hepatobiliary disease with pathological ALP levels found in
approximately 60% of patients with disease of the liver or biliary tract.
• ALP levels may also be elevated in primary bone diseases such as osteomalacia, osteogenesis imperfecta, vitamin D
intoxication and primary bone tumor.
• ALP levels may also be increased in secondary bone diseases such as skeletal metastases and in diseases such as
multiple myeloma, acromegaly, renal insufficiency, hyperthyroidism, ectopic ossification, sarcoidosis, bone
tuberculosis and healing fractures.
• Reduced levels of ALP are found in familial hypophosphatasia, hypoparathyroidism, achondroplasia, adynamic bone
disease in dialysis patients, pituitary dwarfism and chronic radiation sickness.
DR. SUJANA REDDY

MD BIOCHEMISTRY
Page 15 of 21
TEST REPORT

GLYCATED HAEMOGLOBIN (HbA1C)

Glycated Haemoglobin : 5.7 % Non Diabetic : < 5.6
Pre - Diabetic Range : 5.7 - 6.4
Diabetic Range : >/= 6.5
Method: High performance liquid chromatography
Interpretation / Comments:
---------------------------------
• Glycated hemoglobin is proportional to mean plasma glucose level during previous 6-12 weeks.
• Values may not be comparable with different methodologies and even different laboratories using same methodology.
• Perform A1c at least twice annually in diabetes patients to ascertain meeting of goals.
• Perform A1c test quarterly in diabetes patients whose therapy has changed and who are not meeting goals.
• Recommended goal of A1c is < 7%.

• ADA guidelines 2022.
Page 16 of 21
TEST REPORT

GLYCATED HAEMOGLOBIN (HbA1C)

DR. SUJANA REDDY

MD BIOCHEMISTRY
Page 17 of 21
TEST REPORT

Sample Type : Fluoride Plasma Regn Centre : Dilsukhnagar - 12
POST LUNCH GLUCOSE

Post Lunch Glucose : 108 mg/dL Normal : 100 - 140
Method: Hexokinase Impaired Glucose Tolerance : 141 -
199
Diabetes : >/= 200
Interpretation / comments:
---------------------------------
• ADA guidelines (2023) are adopted for the evaluation of diabetic status.
DR. SYED SHABBAR MASIH

MD BIOCHEMISTRY
Registration No: TSMC/FMR/44589
Page 18 of 21
TEST REPORT

Sample Type : Fluoride Plasma Regn Centre : Dilsukhnagar - 12
FASTING PLASMA GLUCOSE

Fasting Plasma Glucose : 85 mg/dL Normal : 70 - 100
Method: Hexokinase Impaired Fasting Glucose : 101 -
125
Diabetes : >/=126
----------------------------------
• ADA guidelines (2023) are adopted for the evaluation of diabetic status.
DR. SUJANA REDDY

MD BIOCHEMISTRY
Page 19 of 21
TEST REPORT

SGOT/AST (ASPARTATE TRANSMINASE)

SGOT/AST : 20 U/L 0 - 35
Method: IFCC without P-5-P
------------------------------------
• Most sensitive test for acute hepatocellular injury (eg. viral, drug) it precedes increase in serum bilirubin by
approximately one week.
DR. SUJANA REDDY

MD BIOCHEMISTRY
------------------ End of Report ------------------
Page 20 of 21
TEST REPORT

T4 TOTAL

T4 Total : 10.50 µg/dL Adult : 3.2 - 12.6
Method: Chemiluminiscence Immunoassay Pregnant : 6.4 - 10.7
-----------------------------------
• Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many
factors such as stress, position, fasting state, time of the day, preceding diet and drug therapy.
• Elevated level of T4 are seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum thyroid binding
globulin (TBG).
• Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG.
DR. SUJANA REDDY

MD BIOCHEMISTRY
------------------ End of Report ------------------
Page 21 of 21

Report

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Report

Uploaded by

Copyright:

Available Formats

VIJAYA DIAGNOSTIC CENTRE, Dilsukhnagar

Age / Gender: 35/Female Date and Time: 23rd Mar 24 10:33 AM

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

DR. SUJANA REDDY

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

DR. SUJANA REDDY

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

COMPLETE BLOOD PICTURE (CBP)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

MCH : 26.4 pg 27.0 - 32.0

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

COMPLETE BLOOD PICTURE (CBP)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Method: Microscopy of Leishman stained smear

DR. NADIA JABEEN

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

CUE (COMPLETE URINE EXAMINATION)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Method: Reagent Strip Method / Double Indicator

DR. NADIA JABEEN

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

DR. SUJANA REDDY

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

DR. SUJANA REDDY

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Method: Calculated Near optimal : 100 - 129

DR. SUJANA REDDY

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

ERYTHROCYTE SEDIMENTATION RATE (ESR)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Rheumatoid arthritis, Systemic Lupus Erythematosus and Pulmonary infarction.

DR. RUDRA PRADEEP

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

DEPARTMENT OF RADIOLOGY AND IMAGING SCIENCES

History : Abdominal distension.

Gall Bladder : Physiologically distended and shows no wall thickening. No obvious

Pancreas : Normal in size, shape and echopattern. No calcifications, duct dilatation

Spleen : Normal in size (89 mm), shape and echopattern.

Kidneys : Right kidney : 102 x 39 mm; Left kidney : 100 x 49 mm

Uterus : Size : 71 x 52 x 38 mm.

Ovaries : Right ovary : 48 x 43 x 20 mm, Volume - 23 cc.

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

DEPARTMENT OF RADIOLOGY AND IMAGING SCIENCES

Other Findings : No free fluid in Pouch of Douglas.

Impression : * GRADE - I FATTY LIVER.

* BILATERAL POLYCYSTIC OVARIES.

FOR CLINICAL CORRELATION / FURTHER EVALUATION.

MIS-2023-0192 DR. SIREESHA P

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

• T3 is one of the thyroid hormones derived due to peripheral conversion of T4.

DR. SUJANA REDDY

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

SGPT / ALT (ALANINE TRANSAMINASE)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

DR. SUJANA REDDY

Name : Mrs. K KARUNA SHREE Registered on : 23-Mar-2024 09:18

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL